| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.26 | 2e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |